Terms: = Lung cancer AND ER, estrogen receptor AND Clinical Outcome
24 results:
1. mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease.
Wege AK; Rom-Jurek EM; Jank P; Denkert C; Ugocsai P; Solbach C; Blohmer JU; Sinn B; van Mackelenbergh M; Möbus V; Trumpp A; Marangoni E; Pfarr N; Irlbeck C; Warfsmann J; Polzer B; Weber F; Ortmann O; Loibl S; Vladimirova V; Brockhoff G
Int J Cancer; 2022 Apr; 150(8):1357-1372. PubMed ID: 34927257
[TBL] [Abstract] [Full Text] [Related]
2. The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
Oh YJ; Park SY; Seo YH
Oncol Rep; 2018 Apr; 39(4):1775-1782. PubMed ID: 29436674
[TBL] [Abstract] [Full Text] [Related]
3. Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast cancers and clinical Implications.
He J; Huo L; Ma J; Zhao J; Bassett RL; Sun X; Ueno NT; Lim B; Gong Y
Am J Clin Pathol; 2018 Feb; 149(3):253-261. PubMed ID: 29425258
[TBL] [Abstract] [Full Text] [Related]
4. ERβ Sensitizes NSCLC to Chemotherapy by Regulating DNA Damage Response.
Nikolos F; Thomas C; Bado I; Gustafsson JÅ
Mol Cancer Res; 2018 Feb; 16(2):233-242. PubMed ID: 29117942
[TBL] [Abstract] [Full Text] [Related]
5. [The clinical characteristics of pulmonary benign metastasizing leiomyoma].
Wang HP; Shi JH; Zhang L
Zhonghua Nei Ke Za Zhi; 2017 Jul; 56(7):490-494. PubMed ID: 28693056
[No Abstract] [Full Text] [Related]
6. ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.
Schlienger S; Campbell S; Pasquin S; Gaboury L; Claing A
Oncotarget; 2016 Mar; 7(13):15811-27. PubMed ID: 26908458
[TBL] [Abstract] [Full Text] [Related]
7. Calreticulin Expression in Human Non-Small Cell lung cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis.
Fucikova J; Becht E; Iribarren K; Goc J; Remark R; Damotte D; Alifano M; Devi P; Biton J; Germain C; Lupo A; Fridman WH; Dieu-Nosjean MC; Kroemer G; Sautès-Fridman C; Cremer I
Cancer Res; 2016 Apr; 76(7):1746-56. PubMed ID: 26842877
[TBL] [Abstract] [Full Text] [Related]
8. Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial.
Jamal-Hanjani M; A'Hern R; Birkbak NJ; Gorman P; Grönroos E; Ngang S; Nicola P; Rahman L; Thanopoulou E; Kelly G; Ellis P; Barrett-Lee P; Johnston SR; Bliss J; Roylance R; Swanton C
Ann Oncol; 2015 Jul; 26(7):1340-6. PubMed ID: 26003169
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract] [Full Text] [Related]
10. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition.
Xiong G; Deng L; Zhu J; Rychahou PG; Xu R
BMC Cancer; 2014 Jan; 14():1. PubMed ID: 24383403
[TBL] [Abstract] [Full Text] [Related]
11. 14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers.
Bergamaschi A; Frasor J; Borgen K; Stanculescu A; Johnson P; Rowland K; Wiley EL; Katzenellenbogen BS
Breast Cancer Res Treat; 2013 Feb; 137(3):689-96. PubMed ID: 23271328
[TBL] [Abstract] [Full Text] [Related]
12. Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome.
Verma MK; Miki Y; Abe K; Nagasaki S; Niikawa H; Suzuki S; Kondo T; Sasano H
Life Sci; 2012 Oct; 91(15-16):800-8. PubMed ID: 22982181
[TBL] [Abstract] [Full Text] [Related]
13. Role of hormone receptor expression in patients with advanced-stage lung cancer treated with chemotherapy.
Monica V; Longo M; Felice B; Scagliotti GV; Papotti M; Novello S
Clin Lung Cancer; 2012 Nov; 13(6):416-23. PubMed ID: 22658344
[TBL] [Abstract] [Full Text] [Related]
14. Oestrogen receptor β in NSCLC - prevalence, proliferative influence, prognostic impact and smoking.
Karlsson C; Helenius G; Fernandes O; Karlsson MG
APMIS; 2012 Jun; 120(6):451-8. PubMed ID: 22583357
[TBL] [Abstract] [Full Text] [Related]
15. Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancer.
Navaratnam S; Skliris G; Qing G; Banerji S; Badiani K; Tu D; Bradbury PA; Leighl NB; Shepherd FA; Nowatzki J; Demers A; Murphy L
Horm Cancer; 2012 Jun; 3(3):93-100. PubMed ID: 22302352
[TBL] [Abstract] [Full Text] [Related]
16. DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference.
Jiao Y; Lawler K; Patel GS; Purushotham A; Jones AF; Grigoriadis A; Tutt A; Ng T; Teschendorff AE
BMC Bioinformatics; 2011 Oct; 12():403. PubMed ID: 22011170
[TBL] [Abstract] [Full Text] [Related]
17. Lack of direct association between EGFR mutations and ER beta expression in lung cancer.
Onitsuka T; Uramoto H; Tanaka F
Anticancer Res; 2011 Mar; 31(3):855-60. PubMed ID: 21498706
[TBL] [Abstract] [Full Text] [Related]
18. Paradoxical relationship between chromosomal instability and survival outcome in cancer.
Birkbak NJ; Eklund AC; Li Q; McClelland SE; Endesfelder D; Tan P; Tan IB; Richardson AL; Szallasi Z; Swanton C
Cancer Res; 2011 May; 71(10):3447-52. PubMed ID: 21270108
[TBL] [Abstract] [Full Text] [Related]
19. Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR-TKI for adenocarcinoma of the lung.
Nose N; Uramoto H; Iwata T; Hanagiri T; Yasumoto K
Lung Cancer; 2011 Mar; 71(3):350-5. PubMed ID: 20615575
[TBL] [Abstract] [Full Text] [Related]
20. Identification of 5 novel genes methylated in breast and other epithelial cancers.
Hill VK; Hesson LB; Dansranjavin T; Dallol A; Bieche I; Vacher S; Tommasi S; Dobbins T; Gentle D; Euhus D; Lewis C; Dammann R; Ward RL; Minna J; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Mar; 9():51. PubMed ID: 20205715
[TBL] [Abstract] [Full Text] [Related]
[Next]
